Chua, Su JenMol, Ben W.Longobardi, SalvatoreOrvieto, RaoulVenetis, Christos A.Lispi, MonicaStorr, AshleighD’Hooghe, Thomas2021-05-102021-05-102021Chua, S J, Mol, B W, Longobardi, S, Orvieto, R, Venetis, C A, Lispi, M, Storr, A & D’Hooghe, T 2021, 'Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F (R)) in couples undergoing assisted reproductive technology treatment : a systematic review and meta-analysis', Reproductive Biology and Endocrinology, vol. 19, no. 1, 51. https://doi.org/10.1186/s12958-021-00727-y1477-7827RIS: urn:765EA6FCFD3429F70EFE0D40A95C2EE3RIS: Chua2021PubMedCentral: PMC8017804https://hdl.handle.net/2164/16424Acknowledgments Authors would like to thank Dr. Rui Wang (Department of Obstetrics and Gynecology, University of Monash) who contributed to the statistical analysis. Medical writing assistance was provided by Evelina Matekonyte, inScience Communications, Springer Healthcare Ltd., London, UK, and funded by Merck KGaA, Darmstadt, Germany. Funding This study was funded by Merck KGaA, Darmstadt, Germany. Merck KGaA (Darmstadt, Germany) designed and approved the study, took part in data collection and data analysis, and contributed to the data interpretation and final draft of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.131877118engBiosimilarFollitropin alfaIVFOvarian stimulationr-hFSHR MedicineSupplementary InformationRJournal article10.1186/s12958-021-00727-y191